查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1612616

血糖監測市場：按產品、測試技術、應用、分銷管道和最終用戶 - 2025-2030 年全球預測

Blood Glucose Monitoring Market by Product, Testing Technology, Application, Distribution Channel, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年血糖監測市場價值為130.6億美元，預計2024年將達到140.8億美元，預計複合年成長率為8.28%，到2030年將達到228億美元。

血糖監測市場的範圍和定義涉及用於測量和追蹤個人（尤其是糖尿病患者）血糖濃度的設備和技術。血糖監測對於管理糖尿病、預防併發症和確保整體健康至關重要。主要用途是供糖尿病患者個人使用，在臨床實踐中用於診斷目的，並且擴大用於連續監測。最終使用者主要是醫院、診所、居家照護機構和個人消費者。推動該市場成長要素包括全球糖尿病盛行率的上升、人們對糖尿病管理益處的認知不斷提高、監測設備的技術進步以及向微創和非侵入性設備的轉變。市場開拓機會包括將人工智慧與數位健康平台相結合以進行遠端監測和更準確的資料分析、開發穿戴式技術以及擴展到糖尿病患者數量不斷增加的新興市場。影響成長的限制和挑戰包括先進監測設備的高成本、低收入地區獲得醫療保健的機會有限以及缺乏對糖尿病自我管理的認知和教育。公司將投資研究更具成本效益的解決方案，並擴展注重患者便利性和易用性的產品，例如長壽命感測器和增強的資料解釋軟體，我認為這可以帶來創新。該市場競爭激烈且技術先進，現有企業和新參與企業都在努力爭取市場佔有率。潛在的創新領域包括開發完全無創的血糖監測技術、提高準確性以及與智慧型手機和智慧型手錶的整合，以及尋求與醫療保健提供者建立合作夥伴關係以改善患者的治療結果。透過專注於個人化糖尿病管理解決方案，公司可以獲得競爭優勢，並順應以人為本的醫療保健日益成長的趨勢。

主要市場統計
基準年[2023] 130.6億美元
預測年份 [2024] 140.8億美元
預測年份 [2030] 228億美元
複合年成長率（%） 8.28%

市場動態：揭示快速發展的血糖監測市場的關鍵市場洞察

供需的動態交互作用正在改變血糖監測市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 糖尿病流行與認知計劃
    • 人們越來越偏好非侵入性技術
    • 家庭護理環境中連續血糖監測的需要
  • 市場限制因素
    • 血糖監測系統召回問題
  • 市場機會
    • 血糖監測系統的設計與功能的進步
    • 加強血糖監測報銷
  • 市場挑戰
    • 血糖監測生產運作複雜性

波特五力：駕馭血糖監測市場的策略工具

波特的五力框架是了解血糖監測市場競爭格局的關鍵工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢、解決弱點並避免潛在的挑戰，以確保更強大的市場地位。

PESTLE分析：了解血糖監測市場的外部影響

外部宏觀環境因素在塑造血糖監測市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解血糖監測市場的競爭格局

對血糖監測市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣血糖監測市場廠商績效評估

FPNV定位矩陣是評估血糖監測市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了血糖監測市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對血糖監測市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 提高糖尿病盛行率和提高認知計劃
      • 人們越來越青睞非侵入性血糖監測技術
      • 持續居家照護的需要
    • 抑制因素
      • 回顧血糖監測系統的負面影響
    • 機會
      • 血糖監測系統的設計與功能的進步
      • 加強血糖監測報銷
    • 任務
      • 創建和操作血糖監測的複雜性
  • 市場區隔分析
    • 產品：提供自我血糖儀的個人指導
    • 測試技術：電極式血糖值監測儀被開發為攜帶式和家用設備的可能性
    • 應用：需要對第 1 型糖尿病進行精確連續監測的高級 CGM
    • 最終用戶：提供血糖值監測儀以最佳化醫院的臨床效率和患者吞吐量
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章血糖監測市場：依產品

  • 連續血糖監測儀
    • 胰島素幫浦
    • 感應器
    • 發送器和接收器
  • 自我或一次性監測
    • 血糖值儀
    • 採血針
    • 試紙

第7章 血糖監測市場測試技術

  • 電極式血糖值儀
  • 光電血糖值儀

第8章血糖監測市場：依應用分類

  • 妊娠糖尿病
  • 1型糖尿病
  • 2型糖尿病

第9章血糖監測市場：依通路分類

  • 離線
  • 線上

第10章血糖監測市場：依最終用戶分類

  • 居家護理
  • 醫院/診所

第11章美洲血糖監測市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第12章亞太血糖監測市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第13章歐洲、中東和非洲血糖監測市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第14章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • 雅培完成 Bigfoot Biomedical 的收購
    • Dexcom 推出新型穿戴式設備，無需胰島素即可協助管理第 2 型糖尿病
    • Astellas來製藥、羅氏糖尿病護理日本公司和 Bluestar 簽署合作協議，開發綜合糖尿病自我管理解決方案並將其商業化
  • 戰略分析和建議

公司名單

  • Abbott Laboratories
  • AdvaCare Pharma
  • Advin Health Care
  • ARKRAY, Inc.
  • Ascensia Diabetes Care Holdings AG by PHC Holdings Corporation
  • B. Braun Melsungen AG
  • BAYER AG
  • Becton, Dickinson and Company
  • Dexcom, Inc.
  • F. Hoffmann-La Roche Ltd.
  • GlySens Incorporated
  • I-SENS, Inc.
  • Insulet Corporation
  • Johnson & Johnson Services, Inc.
  • LifeScan IP Holding, LLC.
  • Medtronic PLC
  • Medtrum Technologies Inc.
  • Nemaura Medical Inc.
  • Nipro Europe Group Companies
  • Nova Biomedical
  • Novo Nordisk A/s
  • NXP Semiconductors NV
  • PHC Holding Corporation
  • Prodigy Diabetes Care LLC
  • Sanofi SA
  • Senseonics Holdings Inc.
  • Sinocare Inc.
  • Teladoc Health, Inc.
  • Terumo Corporation
  • Ypsomed AG
Product Code: MRR-957C47F90031

The Blood Glucose Monitoring Market was valued at USD 13.06 billion in 2023, expected to reach USD 14.08 billion in 2024, and is projected to grow at a CAGR of 8.28%, to USD 22.80 billion by 2030.

The scope and definition of the blood glucose monitoring market pertain to devices and technologies used to measure and track glucose levels in individuals, particularly those with diabetes. Blood glucose monitoring is crucial for managing diabetes, preventing complications, and ensuring overall health. Applications primarily include personal use by individuals with diabetes, in clinical settings for diagnostic purposes, and increasingly for continuous monitoring. End-users are predominantly hospitals, clinics, home care settings, and individual consumers. Key growth factors driving this market include the rising prevalence of diabetes globally, increased awareness about the benefits of diabetes management, technological advancements in monitoring devices, and a shift towards minimally invasive and non-invasive devices. Emerging opportunities in the market include the integration of digital health platforms and AI for remote monitoring and more accurate data analytics, wearable technology development, and expansion in emerging markets where diabetes cases are on the rise. Limitations and challenges affecting growth include high costs of advanced monitoring devices, limited access to healthcare in low-income regions, and lack of awareness or education about self-management of diabetes. Companies could innovate by investing in research for more cost-effective solutions and expanding offerings that focus on patient convenience and ease of use, including long-lasting sensors and enhanced software for data interpretation. The nature of the market is highly competitive with rapid technological advances, with both established companies and new entrants striving to capture market share. Areas of potential innovation include developing fully non-invasive glucose monitoring technologies, improving accuracy and integration with smartphones and smartwatches, and pursuing collaboration with healthcare providers for improved patient outcomes. Focusing on personalized diabetes management solutions could offer companies a competitive edge and align with the growing trend towards individual-centric healthcare.

KEY MARKET STATISTICS
Base Year [2023] USD 13.06 billion
Estimated Year [2024] USD 14.08 billion
Forecast Year [2030] USD 22.80 billion
CAGR (%) 8.28%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Blood Glucose Monitoring Market

The Blood Glucose Monitoring Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Prevalence of diabetes and improved awareness programs
    • Increasing preference for non-invasive blood glucose monitoring technology
    • Need for continuous blood glucose monitoring in-home care settings
  • Market Restraints
    • Adverse recalls of blood glucose monitoring systems
  • Market Opportunities
    • Advancements in design and capabilities of blood glucose monitoring systems
    • Enhancements in the reimbursements for blood glucose monitoring
  • Market Challenges
    • Complexity in the production and operation of blood glucose monitoring

Porter's Five Forces: A Strategic Tool for Navigating the Blood Glucose Monitoring Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Blood Glucose Monitoring Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Blood Glucose Monitoring Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Blood Glucose Monitoring Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Blood Glucose Monitoring Market

A detailed market share analysis in the Blood Glucose Monitoring Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Blood Glucose Monitoring Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Blood Glucose Monitoring Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Blood Glucose Monitoring Market

A strategic analysis of the Blood Glucose Monitoring Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Blood Glucose Monitoring Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AdvaCare Pharma, Advin Health Care, ARKRAY, Inc., Ascensia Diabetes Care Holdings AG by PHC Holdings Corporation, B. Braun Melsungen AG, BAYER AG, Becton, Dickinson and Company, Dexcom, Inc., F. Hoffmann-La Roche Ltd., GlySens Incorporated, I-SENS, Inc., Insulet Corporation, Johnson & Johnson Services, Inc., LifeScan IP Holding, LLC., Medtronic PLC, Medtrum Technologies Inc., Nemaura Medical Inc., Nipro Europe Group Companies, Nova Biomedical, Novo Nordisk A/s, NXP Semiconductors N.V., PHC Holding Corporation, Prodigy Diabetes Care LLC, Sanofi S.A., Senseonics Holdings Inc., Sinocare Inc., Teladoc Health, Inc., Terumo Corporation, and Ypsomed AG.

Market Segmentation & Coverage

This research report categorizes the Blood Glucose Monitoring Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Continuous Blood Glucose Monitors and Self or One Time Monitors. The Continuous Blood Glucose Monitors is further studied across Insulin Pumps, Sensors, and Transmitter & Receiver. The Self or One Time Monitors is further studied across Blood Glucose Meter, Lancets, and Testing Strips.
  • Based on Testing Technology, market is studied across Electrode Type Blood Glucose Monitor and Photoelectric Blood Glucose Monitor.
  • Based on Application, market is studied across Gestational Diabetes, Type 1 Diabetes, and Type 2 Diabetes.
  • Based on Distribution Channel, market is studied across Offline and Online.
  • Based on End-User, market is studied across Home Care and Hospital & Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Prevalence of diabetes and improved awareness programs
      • 5.1.1.2. Increasing preference for non-invasive blood glucose monitoring technology
      • 5.1.1.3. Need for continuous blood glucose monitoring in-home care settings
    • 5.1.2. Restraints
      • 5.1.2.1. Adverse recalls of blood glucose monitoring systems
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancements in design and capabilities of blood glucose monitoring systems
      • 5.1.3.2. Enhancements in the reimbursements for blood glucose monitoring
    • 5.1.4. Challenges
      • 5.1.4.1. Complexity in the production and operation of blood glucose monitoring
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Provision of personalized guidance in self-monitoring blood glucose monitors
    • 5.2.2. Testing Technology: Potential of electrode-type blood glucose monitors to be developed as portable and home-use devices
    • 5.2.3. Application: Need for sophisticated CGMs with accuracy and constant monitoring for type-1 diabetes
    • 5.2.4. End-User: Provision of blood glucose monitors that optimize clinical efficiency and patient throughput in hospitals
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Blood Glucose Monitoring Market, by Product

  • 6.1. Introduction
  • 6.2. Continuous Blood Glucose Monitors
    • 6.2.1. Insulin Pumps
    • 6.2.2. Sensors
    • 6.2.3. Transmitter & Receiver
  • 6.3. Self or One Time Monitors
    • 6.3.1. Blood Glucose Meter
    • 6.3.2. Lancets
    • 6.3.3. Testing Strips

7. Blood Glucose Monitoring Market, by Testing Technology

  • 7.1. Introduction
  • 7.2. Electrode Type Blood Glucose Monitor
  • 7.3. Photoelectric Blood Glucose Monitor

8. Blood Glucose Monitoring Market, by Application

  • 8.1. Introduction
  • 8.2. Gestational Diabetes
  • 8.3. Type 1 Diabetes
  • 8.4. Type 2 Diabetes

9. Blood Glucose Monitoring Market, by Distribution Channel

  • 9.1. Introduction
  • 9.2. Offline
  • 9.3. Online

10. Blood Glucose Monitoring Market, by End-User

  • 10.1. Introduction
  • 10.2. Home Care
  • 10.3. Hospital & Clinics

11. Americas Blood Glucose Monitoring Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Blood Glucose Monitoring Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Blood Glucose Monitoring Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. Abbott Completes Acquisition Of Bigfoot Biomedical
    • 14.3.2. Dexcom Announces Novel Wearable For Managing Type 2 Diabetes - Without Insulin
    • 14.3.3. Astellas and Roche Diabetes Care Japan Ink Partnership Agreement To Develop And Commercialize Integrated Diabetes Self-Management Solution with BlueStar
  • 14.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. AdvaCare Pharma
  • 3. Advin Health Care
  • 4. ARKRAY, Inc.
  • 5. Ascensia Diabetes Care Holdings AG by PHC Holdings Corporation
  • 6. B. Braun Melsungen AG
  • 7. BAYER AG
  • 8. Becton, Dickinson and Company
  • 9. Dexcom, Inc.
  • 10. F. Hoffmann-La Roche Ltd.
  • 11. GlySens Incorporated
  • 12. I-SENS, Inc.
  • 13. Insulet Corporation
  • 14. Johnson & Johnson Services, Inc.
  • 15. LifeScan IP Holding, LLC.
  • 16. Medtronic PLC
  • 17. Medtrum Technologies Inc.
  • 18. Nemaura Medical Inc.
  • 19. Nipro Europe Group Companies
  • 20. Nova Biomedical
  • 21. Novo Nordisk A/s
  • 22. NXP Semiconductors N.V.
  • 23. PHC Holding Corporation
  • 24. Prodigy Diabetes Care LLC
  • 25. Sanofi S.A.
  • 26. Senseonics Holdings Inc.
  • 27. Sinocare Inc.
  • 28. Teladoc Health, Inc.
  • 29. Terumo Corporation
  • 30. Ypsomed AG

LIST OF FIGURES

  • FIGURE 1. BLOOD GLUCOSE MONITORING MARKET RESEARCH PROCESS
  • FIGURE 2. BLOOD GLUCOSE MONITORING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS BLOOD GLUCOSE MONITORING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. AMERICAS BLOOD GLUCOSE MONITORING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 19. UNITED STATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA BLOOD GLUCOSE MONITORING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA BLOOD GLUCOSE MONITORING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. BLOOD GLUCOSE MONITORING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 25. BLOOD GLUCOSE MONITORING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. BLOOD GLUCOSE MONITORING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. BLOOD GLUCOSE MONITORING MARKET DYNAMICS
  • TABLE 7. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY INSULIN PUMPS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY SENSORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY TRANSMITTER & RECEIVER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY BLOOD GLUCOSE METER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY LANCETS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING STRIPS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY ELECTRODE TYPE BLOOD GLUCOSE MONITOR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY PHOTOELECTRIC BLOOD GLUCOSE MONITOR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY GESTATIONAL DIABETES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY TYPE 1 DIABETES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY TYPE 2 DIABETES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY OFFLINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY HOME CARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY HOSPITAL & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS BLOOD GLUCOSE MONITORING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 40. ARGENTINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
  • TABLE 41. ARGENTINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
  • TABLE 42. ARGENTINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 43. ARGENTINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. ARGENTINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 45. ARGENTINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 46. BRAZIL BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 47. BRAZIL BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
  • TABLE 48. BRAZIL BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
  • TABLE 49. BRAZIL BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 50. BRAZIL BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. BRAZIL BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 52. BRAZIL BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 53. CANADA BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 54. CANADA BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
  • TABLE 55. CANADA BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
  • TABLE 56. CANADA BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 57. CANADA BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. CANADA BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 59. CANADA BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 60. MEXICO BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 61. MEXICO BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
  • TABLE 62. MEXICO BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
  • TABLE 63. MEXICO BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 64. MEXICO BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. MEXICO BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 66. MEXICO BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 67. UNITED STATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 68. UNITED STATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
  • TABLE 69. UNITED STATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
  • TABLE 70. UNITED STATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 71. UNITED STATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. UNITED STATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 73. UNITED STATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 74. UNITED STATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 75. ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 76. ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
  • TABLE 77. ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
  • TABLE 78. ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 79. ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 81. ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 82. ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 83. AUSTRALIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 84. AUSTRALIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
  • TABLE 85. AUSTRALIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
  • TABLE 86. AUSTRALIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 87. AUSTRALIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. AUSTRALIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 89. AUSTRALIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 90. CHINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 91. CHINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
  • TABLE 92. CHINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
  • TABLE 93. CHINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 94. CHINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. CHINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 96. CHINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 97. INDIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 98. INDIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
  • TABLE 99. INDIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
  • TABLE 100. INDIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 101. INDIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. INDIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 103. INDIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 104. INDONESIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 105. INDONESIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
  • TABLE 106. INDONESIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
  • TABLE 107. INDONESIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 108. INDONESIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. INDONESIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 110. INDONESIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 111. JAPAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 112. JAPAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
  • TABLE 113. JAPAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
  • TABLE 114. JAPAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 115. JAPAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 116. JAPAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 117. JAPAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 118. MALAYSIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 119. MALAYSIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
  • TABLE 120. MALAYSIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
  • TABLE 121. MALAYSIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 122. MALAYSIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. MALAYSIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 124. MALAYSIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 125. PHILIPPINES BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 126. PHILIPPINES BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
  • TABLE 127. PHILIPPINES BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
  • TABLE 128. PHILIPPINES BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 129. PHILIPPINES BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. PHILIPPINES BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 131. PHILIPPINES BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 132. SINGAPORE BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 133. SINGAPORE BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
  • TABLE 134. SINGAPORE BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
  • TABLE 135. SINGAPORE BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 136. SINGAPORE BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 137. SINGAPORE BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 138. SINGAPORE BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 139. SOUTH KOREA BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 140. SOUTH KOREA BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
  • TABLE 141. SOUTH KOREA BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
  • TABLE 142. SOUTH KOREA BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 143. SOUTH KOREA BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. SOUTH KOREA BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 145. SOUTH KOREA BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 146. TAIWAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 147. TAIWAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
  • TABLE 148. TAIWAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
  • TABLE 149. TAIWAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 150. TAIWAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 151. TAIWAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 152. TAIWAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 153. THAILAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 154. THAILAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
  • TABLE 155. THAILAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
  • TABLE 156. THAILAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 157. THAILAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 158. THAILAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 159. THAILAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 160. VIETNAM BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 161. VIETNAM BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
  • TABLE 162. VIETNAM BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
  • TABLE 163. VIETNAM BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 164. VIETNAM BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 165. VIETNAM BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 166. VIETNAM BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 167. EUROPE, MIDDLE EAST & AFRICA BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 168. EUROPE, MIDDLE EAST & AFRICA BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
  • TABLE 169. EUROPE, MIDDLE EAST & AFRICA BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
  • TABLE 170. EUROPE, MIDDLE EAST & AFRICA BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 171. EUROPE, MIDDLE EAST & AFRICA BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 172. EUROPE, MIDDLE EAST & AFRICA BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 173. EUROPE, MIDDLE EAST & AFRICA BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 174. EUROPE, MIDDLE EAST & AFRICA BLOOD GLUCOSE MONITORING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 175. DENMARK BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 176. DENMARK BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
  • TABLE 177. DENMARK BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
  • TABLE 178. DENMARK BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 179. DENMARK BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 180. DENMARK BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 181. DENMARK BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 182. EGYPT BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 183. EGYPT BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
  • TABLE 184. EGYPT BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
  • TABLE 185. EGYPT BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 186. EGYPT BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 187. EGYPT BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 188. EGYPT BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 189. FINLAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 190. FINLAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
  • TABLE 191. FINLAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
  • TABLE 192. FINLAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 193. FINLAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 194. FINLAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 195. FINLAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 196. FRANCE BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 197. FRANCE BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
  • TABLE 198. FRANCE BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
  • TABLE 199. FRANCE BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 200. FRANCE BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 201. FRANCE BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 202. FRANCE BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 203. GERMANY BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 204. GERMANY BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
  • TABLE 205. GERMANY BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
  • TABLE 206. GERMANY BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 207. GERMANY BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 208. GERMANY BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 209. GERMANY BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 210. ISRAEL BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 211. ISRAEL BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
  • TABLE 212. ISRAEL BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
  • TABLE 213. ISRAEL BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 214. ISRAEL BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 215. ISRAEL BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 216. ISRAEL BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 217. ITALY BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 218. ITALY BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
  • TABLE 219. ITALY BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
  • TABLE 220. ITALY BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 221. ITALY BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 222. ITALY BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 223. ITALY BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 224. NETHERLANDS BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 225. NETHERLANDS BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
  • TABLE 226. NETHERLANDS BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
  • TABLE 227. NETHERLANDS BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 228. NETHERLANDS BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 229. NETHERLANDS BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 230. NETHERLANDS BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 231. NIGERIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 232. NIGERIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
  • TABLE 233. NIGERIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
  • TABLE 234. NIGERIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 235. NIGERIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 236. NIGERIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 237. NIGERIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 238. NORWAY BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 239. NORWAY BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
  • TABLE 240. NORWAY BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
  • TABLE 241. NORWAY BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 242. NORWAY BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 243. NORWAY BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 244. NORWAY BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 245. POLAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 246. POLAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
  • TABLE 247. POLAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
  • TABLE 248. POLAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 249. POLAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 250. POLAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 251. POLAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 252. QATAR BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 253. QATAR BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
  • TABLE 254. QATAR BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
  • TABLE 255. QATAR BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 256. QATAR BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 257. QATAR BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 258. QATAR BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 259. RUSSIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 260. RUSSIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
  • TABLE 261. RUSSIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
  • TABLE 262. RUSSIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 263. RUSSIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 264. RUSSIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 265. RUSSIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 266. SAUDI ARABIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 267. SAUDI ARABIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
  • TABLE 268. SAUDI ARABIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
  • TABLE 269. SAUDI ARABIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 270. SAUDI ARABIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 271. SAUDI ARABIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 272. SAUDI ARABIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 273. SOUTH AFRICA BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 274. SOUTH AFRICA BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
  • TABLE 275. SOUTH AFRICA BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
  • TABLE 276. SOUTH AFRICA BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 277. SOUTH AFRICA BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 278. SOUTH AFRICA BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 279. SOUTH AFRICA BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 280. SPAIN BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 281. SPAIN BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
  • TABLE 282. SPAIN BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
  • TABLE 283. SPAIN BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 284. SPAIN BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 285. SPAIN BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 286. SPAIN BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 287. SWEDEN BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 288. SWEDEN BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
  • TABLE 289. SWEDEN BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
  • TABLE 290. SWEDEN BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 291. SWEDEN BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 292. SWEDEN BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 293. SWEDEN BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 294. SWITZERLAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 295. SWITZERLAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
  • TABLE 296. SWITZERLAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
  • TABLE 297. SWITZERLAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 298. SWITZERLAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 299. SWITZERLAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 300. SWITZERLAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 301. TURKEY BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 302. TURKEY BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
  • TABLE 303. TURKEY BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
  • TABLE 304. TURKEY BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 305. TURKEY BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 306. TURKEY BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 307. TURKEY BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 308. UNITED ARAB EMIRATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 309. UNITED ARAB EMIRATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
  • TABLE 310. UNITED ARAB EMIRATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
  • TABLE 311. UNITED ARAB EMIRATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 312. UNITED ARAB EMIRATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 313. UNITED ARAB EMIRATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 314. UNITED ARAB EMIRATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 315. UNITED KING